| UHC UMR Medical and Drug | Clinical Trials - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Clotting Factors, Coagulant Blood Products, & Other Hemostatics - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Cochlear Implants - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Cognitive Rehabilitation and Coma Stimulation - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Collagen Crosslinks and Biochemical Markers of Bone Turnover - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Complement Inhibitors - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Continuous Glucose Monitoring and Insulin Delivery for Managing Diabetes - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Cosmetic and Reconstructive Procedures - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Denosumab - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Diagnostic Dynamic Spinal Visualization and Vertebral Motion Analysis - Commercial and Individual Exchange Medical Policy | 2026-01-01 |